4th Quarter - Amendment

BLANK ROME GOVERNMENT RELATIONS for MYLAN LABORATORIES INC

Firm
Client
Income
$50,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 21, 2014 $50,000 Replaced
4th Quarter - Amendment (this page) Feb 7, 2014 $50,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

S. 214, Preserve Access to Affordable Generics Act

LobbyistCovered position, as disclosed
ASHLEY DAVIS —
MALLOY MCDANIEL —
KRISTI REMINGTON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 214 (113th)

Foreign Relations FOR

PEPFAR Stewardship and Oversight Act of 2013 (S. 1545 / H.R. 3177)

LobbyistCovered position, as disclosed
ASHLEY DAVIS —
MALLOY MCDANIEL —
KRISTI REMINGTON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1545 (113th), H.R. 3177 (113th)

Torts TOR

State preemption issues

LobbyistCovered position, as disclosed
KRISTI REMINGTON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013

LobbyistCovered position, as disclosed
ASHLEY DAVIS —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 486 (113th), H.R. 2094 (113th), S. 957 (113th), S. 504 (113th), S. 621 (113th), H.R. 460 (113th), S. 959 (113th), H.R. 1285 (113th), H.R. 1919 (113th), H.R. 8 (113th)

Budget/Appropriations BUD

FY 2014 Appropriations; President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund; Generic Drug User Fees; Biosimilar User Fees; Funding for FDA; Funding for the Office of Generic Drugs; FY14 Presidential Budget Request

LobbyistCovered position, as disclosed
ASHLEY DAVIS —
MALLOY MCDANIEL —
KRISTI REMINGTON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.